Background {#Sec1}
==========

Plants biosynthesize various natural products that protect them from being eaten by herbivores. Herbivore insects can detoxify these phytotoxic molecules and can biosynthesize various molecules including pheromones. Fungi are also a source of valuable natural products such as antibiotics. Secondary metabolites are species-specific natural products that are not directly involved in the species survival. Secondary metabolites and their derivatives are used widely in medicines, cosmetics, and agriculture. For example, penicillin, which was discovered by Fleming in 1928 \[[@CR1]\], was widely used as an antibiotic against infectious diseases, and avermectin, which was discovered by Omura in 1979 \[[@CR2]\], is widely used as an anti-parasite drug for pets.

Identifying the biosynthetic route of natural products is not only of pharmacological interest, but is also required by engineers and biologists who use synthetic biology techniques \[[@CR3]--[@CR8]\]. Synthetic biologists aim to synthesize desired molecules enzymatically by introducing foreign genes into an organism such as *Saccharomyces cerevisiae*. The biosynthesis need not necessarily mimic the actual biosynthetic pathway of the target molecule, but knowing the actual metabolic pathway can be very useful when constructing the pathway in a model organism.

However, although the chemical structures of a large number of metabolites are known, the metabolic pathways that lead to their synthesis are not yet known. Moreover, the recent development of high-throughput sequencers and metabolome analysis technology has revealed a large number of natural products for which the biosynthetic metabolic pathways are unknown. Currently, the identification of relevant enzymes in a putative pathway is carried out by trial and error based on knowledge and experience; therefore, an information science-based approach is highly desirable.

A large variety of natural products are produced from a limited variety of starting materials \[[@CR9]\]. In this paper, we define a biosynthetic unit (BU) as a chemical substructure that is part of the starting material. Natural products can be disassembled into the same BUs or into several different BUs to help elucidate their biosynthetic pathways.

In organic synthesis, retrosynthetic analysis is used to design the synthetic route of a target molecule. The retrosynthetic analysis method uses the target molecule and constructs the route backward from the target molecule to the starting material. A similar approach can be applied to metabolic pathway prediction; however, the number of iterations required to generate all virtual reactions can easily explode, making it difficult to find an optimal solution in a finite time. In a previous study, machine learning was applied to decide whether a pair of metabolite molecules could form an enzymatic reaction, thereby showing the potential to predict the metabolic pathway \[[@CR10]\]. Another previous study \[[@CR11]\] is based on similarity search to find potential precursors, i.e., the compounds that are possibly reachable in artificially designed pathway in one step. However, these approaches only deal with one-step reactions in the metabolic pathways, and therefore do not consider the putative intermediates between the target molecule and the starting material. In other studies, retrosynthetic approach often failed to reach the starting material \[[@CR3]--[@CR8], [@CR12]\]. To use the retrosynthetic approach for natural product biosynthesis, it is important to develop a workflow that can identify the appropriate starting materials.

In this study, we developed a workflow named the Metabolic Disassembler to automatically identify the BUs that corresponded to the starting materials of a given natural product. One of the important characteristics is that our method "disassembles" a given molecule into substructures that imply the starting materials. The aim was to provide support for identifying biosynthesis pathways. We evaluated the performance of the Metabolic Disassembler using datasets of secondary metabolites acquired from the Kyoto Encyclopedia of Genes and Genomes (KEGG) database \[[@CR13]\], and showed the effectiveness of the workflow in terms of both accuracy and computational time. The users of the Metabolic Disassembler do not have to specify starting molecules in advance, and can input any target molecule, even if it is not in databases.

Methods {#Sec2}
=======

Chemical structures of natural products {#Sec3}
---------------------------------------

The goal of the Metabolic Disassembler is not to construct artificial pathways, but is to know the actual metabolic pathways of natural products. In order to achieve our goal, compounds and reactions in primary (central) metabolism are not needed. Rather, they are a hindrance to the calculation. Also, if a secondary metabolite is not associated with known biosynthetic pathway, no one would estimate if the prediction is true. Therefore, we need to collect secondary metabolites for which biosynthetic pathways are already known. We surveyed databases including MetaCyc \[[@CR14]\] and Rhea \[[@CR15]\], and concluded that KEGG \[[@CR13]\] (as of November 2018) is the one that stores necessary and sufficient amount of information.

In KEGG, metabolic compounds are given identifiers that contain the letter "C" and a five-digit number (e.g., "C00078" for L-tryptophan). We also used KEGG PATHWAY secondary metabolism maps to evaluate the accuracy of disassembly. In KEGG PATHWAY, secondary metabolism is classified as 1.9 "Metabolism of terpenoids and polyketides" (hereafter referred to as the 1.9 class) and 1.10 "Biosynthesis of other secondary metabolites" (hereafter referred to as the 1.10 class). The 1.9 class contains a group of molecules that are biosynthesized through mevalonate or non-mevalonate pathways, and BUs in these pathways are mostly limited to C~2~ and C~5~ units. This means that it is not difficult to identify these BUs because they are already quite obvious, and it is more important to analyze how the BUs form complex rings. Therefore, in this study, we focused on the 1.10 class, which contains 1111 molecules in 28 metabolic pathway maps. Molecules that had an "R" group, indicating they contained undefined structures, caused errors when using RDKit \[[@CR16]\], and therefore were not used. The remaining 943 molecules were used in this study. Note that we used KEGG just because it covers all known pathways, and used KEGG PATHWAY just to test the performance. We designed the Metabolic Disassembler so that the users can input any molecule even if it is not found in any database. Note again that we did not focus on the primary (central) metabolites, because all secondary metabolites originate from the starting compounds in the secondary pathway maps. Therefore, in order to find the starting materials of unknown secondary metabolites, it is more practical to use them, rather than the primary (central) metabolites.

Chemical structure manipulation and computing environment {#Sec4}
---------------------------------------------------------

We implemented our application software using Python programming language (version 3.6.6) on Anaconda3 (version 5.3.0) \[[@CR17]\], NetworkX (version 2.2) \[[@CR18]\], RDKit (version 2018.09.1.0) \[[@CR16]\], Pycairo (version 1.18.0) \[[@CR19]\], and CairoSVG (version 2.2.1) \[[@CR20]\]. NetworkX is a graph calculation library that we used to produce the chemical structure graphs. RDKit is used widely in chemoinformatics, and we used it when retrieving chemical structures and conducting maximum common substructure searches. Pycairo and CairoSVG were used to render images of the molecules. The chemical structure of a molecule was represented as a chemical graph with atoms as nodes and chemical bonds as edges. Chemical structures described in MDL Molfile V2000 \[[@CR21]\] were retrieved using RDKit and converted to chemical graphs using NetworkX. All calculations were conducted on a computer with an Intel Core i7-9700K 3.6 GHz CPU and 16 GB RAM in Windows 10 OS.

Generating a biosynthetic unit library (BUL) {#Sec5}
--------------------------------------------

Some minimal units for the biosynthesis of natural products are known, including the acetate-C~2~ unit in the malonic acid pathway and the C~5~ unit in the isoprenoid pathway. The goal of this study was to identify the starting materials and to provide information that can be used to predict the biosynthesis pathway; therefore, it is more useful practically to deal with substructures that are larger than the minimal units, which correspond to the metabolites located near the boundary area of primary and secondary metabolism. We defined three types of biosynthetic units (BUs), basic BUs (BBUs), derivative BUs (DBUs), and preferential BUs (PBUs), and stored them in a biosynthetic unit library (BUL).

The BBUs were defined as important intermediates in biosynthetic pathways and included the molecules in the starting point of a pathway map, the molecules at the branches of a pathway, and the molecule generated immediately after a large structural change. Examples of BBUs are shown in Fig. [1](#Fig1){ref-type="fig"}. The DBUs were identified as derivatives of BBUs by applying 14 chemical transformation rules (i.e., dehydroxylation, decarboxylation, deamination, decarbonylation, oxidative deamination, amino transfer, dentrolation, dephoshorylation, dihidrogenation/de-dihydrogenation, de-CoA, denucleotidylation, ring opening, ring closure, and hydrolysis). We obtained a set of 765 BUs from 257 BBUs and 542 DBUs. The final number was less than the sum of BBUs and DBUs because there were some common structures. Fig. 1Example of a basic set of selected biosynthetic units (BBUs). BBUs were defined as important intermediates in the biosynthetic pathways. In this context, the important intermediates are the molecules in the starting point of the pathway map, the molecules at the branches of the pathway, and the molecule generated immediately after the large structural change. We followed the distinction of solid and dashed arrows as drawn in the KEGG PATHWAY database. In general, solid arrows represent the reactions for which enzymes and reactions have been well characterized, and dashed arrows represent connections to other pathway maps, or reactions that are not yet well characterized

Some substructures, such as the glucose residue in glucosides, remain unchanged downstream in the biosynthetic pathway. To avoid an unnecessary increase in computational costs, we defined a set of PBUs that contained five monosaccharide residues, a shikimic acid moiety, and a betalamic acid moiety (Fig. [2](#Fig2){ref-type="fig"}). Fig. 2Set of preferential biosynthetic units (PBU)

The metabolic disassembler workflow {#Sec6}
-----------------------------------

The workflow consists of five steps: (1) input the target molecule as a query, (2) generate a query-specific BUL, (3) generate the fragment network, (4) generate and sort the BU combination candidates, and (5) output the calculation result.

First, a user inputs the target molecule as a query. Acceptable file formats are Molfile, SMILES (Simplified Molecular Input Line Entry System) \[[@CR22]\], InChI (International Chemical Identifier) \[[@CR23]\], and the KEGG compound identifier \[[@CR13]\]. The input chemical structure is converted to the Mol object of RDKit \[[@CR16]\] and is subsequently processed using NetworkX \[[@CR18]\].

Second, each BU in the BUL is compared with the query structure. If the BU is part of the query structure, it is placed in the query-specific BUL. The aim of this process is to avoid unnecessary computation cost by removing BUs not included in the query molecule. The flowchart for generating a query-specific BUL is shown in Fig. [3](#Fig3){ref-type="fig"}. We used the HasSubstructMatch method in the RDKit library with the following option: Fig. 3The flowchart for generating a query-specific biosynthetic unit library (BUL)

rdkit.Chem.HasSubstructMatch((Mol)self, (Mol)query, useChirality = True).

This method returns *True* if the query contains the given substructure, and returns *False* if not. Stereoisomers are distinguished, as shown in the example in Fig. [4a](#Fig4){ref-type="fig"}. Aromatic bonds are strictly distinguished from other conjugated double bonds, as shown in the example in Fig. [4b](#Fig4){ref-type="fig"}. This is an advantage in many cases; however, it is not useful in this study because aromatization and de-aromatization reactions are observed more frequently in biosynthetic reactions than in organic synthesis. To rescue such cases, we applied some empirical rules as follows. If the query molecule contains ≥17 aromatic bonds, the Metabolic Disassembler uses the FindMCS method \[[@CR16]\] and rescues the falsely judged substructures. Fig. 4Distinguishing stereoisomers and double and aromatic bonds. (**a**) Example of distinguishing stereoisomers by RDKit.D-glucose with unclear stereoisomerism at 1-OH and α-D-glucose were regarded as being included in the target structure, whereas β-D-Glucose and α-D-Mannose were not. (**b**) Example of distinguishing double and aromatic bonds. Structure 1 was not regarded as being included in Structure 2 when using the HasSubstructMatch method in RDKit, because it distinguishes double and aromatic bonds (in red)

rdkit.Chem.rdFMCS.FindMCS(mols, bondCompare = rdkit.Chem.rdFMCS.BondCompare.CompareAny).

The FindMCS method finds the maximum common substructure (MCS) in two or more molecules. Using the options as described above, bond orders such as aromatic and double bonds are ignored, thereby enabling an ambiguous MCS search. However, allowing too many ambiguous bonds produces an excessive number of candidate units. Therefore, the Metabolic Disassembler rescues a substructure only if the ratio of the number of ambiguous bonds to conjugated double bonds in the resulting MCS is ≤0.2. After collecting the units for the query-specific BUL, the units are sorted in decreasing order of the number of the atoms they contain.

Third, the query molecule is divided repeatedly until every fragment matches a BU in the query-specific BUL, and a fragment network is generated to represent the relationship between the query molecule and the obtained fragments (Fig. [5](#Fig5){ref-type="fig"}). The fragment network is traversed to find the optimal combination of BUs. The MCS result is used to identify the bond that needs to be digested for fragmentation. The MCS for this process is: Fig. 5Example of the fragmentation process. One of the BUs is used in a substructure search against the target molecule to identify the bond to digest. Splitting the identified bond yields fragmentation

rdkit.Chem.GetSubstructMatch((Mol)self, (Mol)query, useChirality = True).

The flowchart used to obtain the fragment network has two stages (Fig. [6](#Fig6){ref-type="fig"}). In the first stage ("A" in Fig. [6](#Fig6){ref-type="fig"}), the first fragmentation is carried out by MCS against all the query-specific BUs or PBUs to find the digested bond. The second stage ("B" in Fig. [6](#Fig6){ref-type="fig"}) consists of a nested loop, which repeats digestion until every fragment matches a BU. To reduce the number of candidate BU combinations, the maximum number of selected BUs is decided by eq. (1), where N is the total number of BUs in the query-specific BUL. Fig. 6The flowchart for obtaining the fragment network

n = ⌈ N/2 ⌉ (1).

An example of a fragment network produced by the above process is shown in Fig. [7](#Fig7){ref-type="fig"}. The fragment network represents the relationship between parent (i.e., before the split) and child (i.e., after the split) fragments. An example of this relationship is shown in Fig. [8a](#Fig8){ref-type="fig"}. Fig. 7Example fragment network. (Top) Schematic diagram where the same molecules or fragments are given the same IDs. (Bottom) The same diagram where the detailed chemical structures are described Fig. 8Relationship of parent and child fragments and an example of the queue structure. (**a**) Example of the parent-child relationship from the fragment network. Panel A shows the initial fragmentation; panel B shows the further fragmentation. (**b**) Queue-based procedure to obtain BU candidates

Fourth, using the parent-child relationship, a parent fragment can be replaced by child fragments, and this process can be iterated using the queue data structure (Fig. [8b](#Fig8){ref-type="fig"}). The fragment combination retrieved from the queue is checked to find whether it is identical to any one of the BUs in the query-specific BUL. If it is not, the replaced combination is again inserted into the queue structure as long as the number of fragments does not exceed the upper limit, which is determined in advance by the number of atoms included in the query molecule, as defined by eq. (2).

limit~init~ = ⌈ N/k ⌉ (2).

where, k = {1 if *N* ≤ 4; 3 if 5 ≤ *N* ≤ 24; 4 if 25 ≤ *N* ≤ 53; 6 if 54 ≤ N}.

If every fragment is identical to one of the BUs in the query-specific BUL, the combination is added to the candidate list. The obtained candidate combinations are sorted in descending order of the size of the largest fragment as the first priority, and ascending order of the number of fragments as the second priority. An example of a sorted candidate list is shown in Table [1](#Tab1){ref-type="table"}. Table 1Example of the sorted biosynthetic unit (BU) candidate list. The red dotted lines indicate the bond to be digested. NaN means there are no corresponding substructures or fragments. In this example, the top candidate is the best because it contains the largest fragment, and the number of the fragment is also the largestThe red dotted lines indicate the bond to be digested. NaN means there are no corresponding substructures or fragments. In this example, the top candidate is the best because it contains the largest fragment, and the number of the fragment is also the largest

Finally, to easily understand the optimized BU combination, the Metabolic Disassembler outputs a colored image describing the fragmentation, as shown in the example in Fig. [9](#Fig9){ref-type="fig"}. Each of the split fragments is linked to the starting material. Fig. 9Color-coded output representing the best fragmentation

Comparison of the performance with the system that is not knowledge-based {#Sec7}
-------------------------------------------------------------------------

Since none of previous studies aimed to find starting materials of secondary metabolites directly, it is difficult to show the performance of our proposed workflow. Here, the performance of our proposed workflow, which is a knowledge-based system, was compared with that of a baseline approach using a genetic algorithm, which is not knowledge-based. We used the Python library named DEAP \[[@CR24]\] (version 1.1.2) to implement the genetic algorithm. In the genetic algorithm, the disassembly of the query molecule into BUs was solved as an optimization problem of the digested bonds in the query molecule (Fig. [10](#Fig10){ref-type="fig"}), as explained below. Fig. 10Baseline workflow using the genetic algorithm. An individual represents the combination of digested bonds, and the fitness function was defined as the minimum similarity between the fragments and the BUs in the query-specific BUL

First, N individuals are generated randomly as the first generation, where an individual is represented as a binary (0 or 1) vector that represents whether or not the corresponding bond should be digested. The fitness function decides whether an individual survives, and those that survive are subjected to any of three operations, namely the crossover of two individuals, mutation of an individual, or simply the copy of an individual. The generated N individuals are referred to as the next generation. This process is repeated until the predetermined ending condition is reached, and the individuals with highest fitness at the final generation are regarded as the best solution.

In this study, we set the population (the number of individuals in a generation) to 300, the crossover probability to 80%, and the mutation probability to 0.5%. The fitness function was defined as the minimum similarity between the fragments and the BUs in the query-specific BUL. We used the Tanimoto coefficient of the Morgan fingerprint (radius 2, 1024 bit) \[[@CR25]\] as the similarity measure.

Results {#Sec8}
=======

Performance evaluation {#Sec9}
----------------------

A summary of the ratio of correct disassembly for the respective pathway maps is shown in Table [2](#Tab2){ref-type="table"}. Note that the Metabolic Disassembler inputs only the chemical structure of the query molecule and does not require any pathway information. We used the pathway maps only for the performance evaluation. We found that 903 of the 943 molecules (approximately 96%) were disassembled correctly. Detailed results are presented in Additional file [1](#MOESM1){ref-type="media"}. Table 2Accuracy of the proposed Metabolic Disassembler workflow for each metabolic mapMap numberName of the pathway mapCorrectness for the first candidateCorrectness for the other candidatesIncorrectNumber of moleculesAccuracy00231Puromycin biosynthesis1000101.00000232Caffeine metabolism1400141.00000254Aflatoxin biosynthesis1704210.81000261Monobactam biosynthesis1860241.00000311Penicillin and cephalosporin biosynthesis1200121.00000331Clavulanic acid biosynthesis62081.00000332Carbapenem biosynthesis2201230.95700333Prodigiosin biosynthesis1010110.09100401Novobiocin biosynthesis1701180.94400402Benzoxazinoid biosynthesis60061.00000403Indole diterpene alkaloid biosynthesis3000301.00000404Staurosporine biosynthesis3200321.00000405Phenazine biosynthesis1753250.88000521Streptomycin biosynthesis1500151.00000524Neomycin, kanamycin and gentamicin biosynthesis6702690.97100525Acarbose and validamycin biosynthesis2900291.00000901Indole alkaloid biosynthesis5411560.98200940Phenylpropanoid biosynthesis5104550.92700941Flavonoid biosynthesis6300631.00000942Anthocyanin biosynthesis6300631.00000943Isoflavonoid biosynthesis5522590.96600944Flavone and flavonol biosynthesis4900491.00000945Stilbenoid, diarylheptanoid and gingerol biosynthesis2120231.00000950Isoquinoline alkaloid biosynthesis9801990.99000960Tropane, piperidine and pyridine alkaloid biosynthesis44311580.81000965Betalain biosynthesis2000201.00000966Glucosinolate biosynthesis4850531.00001058Acridone alkaloid biosynthesis1410151.000Total (without redundancy)87627409430.958

Computational time {#Sec10}
------------------

We measured the computational time for the Metabolic Disassembler with the 943 molecules, executed in the computing environment described in Methods. We performed the calculation five times for each molecule and the obtained average values were recorded (Table [3](#Tab3){ref-type="table"}). The plot of the computational time for each molecule is shown in Fig. [11](#Fig11){ref-type="fig"}. One of the molecules needed more than one day for the calculation, so it was excluded from the result. Therefore, the total number of molecules disassembled was 942. Among them, 855 molecules (approximately 91%) were each disassembled within one minute, indicating the processing speed was sufficiently practical in the current implementation. Sixteen molecules took more than 5 min to disassemble (Table [4](#Tab4){ref-type="table"}). One of the causes of the increased execution time came from the application of the FindMCS method in RDKit. Table 3Distribution of computational times for correct and incorrect disassemblyRuntime (s)AverageMedianSDMaxMinCorrect answers (*n* = 903)27.52.0121.02566.00.3Incorrect answers (*n* = 39)4.01.27.837.10.1All (*n* = 942)26.52.0118.62566.00.1 Fig. 11Plot of computational time for each molecule. The computational time is given using a log scale Table 4The molecules that needed more than five minutes of computational time for disassembly

Comparison between the metabolic disassembler and the baseline workflow using a genetic algorithm {#Sec11}
-------------------------------------------------------------------------------------------------

For the fair comparison to our proposed workflow, we measured the computational time of the baseline workflow and decided the number of generations to 200, so that it takes approximately similar range of computational time. The average and maximum runtimes were 252 and 1512 s, respectively, showing that the computational time was not different significantly from our proposed workflow. Also, in the evaluation process of the baseline workflow, we took top five most fitted individuals, and regarded as correct if one of them is correctly disassembled. Table [5](#Tab5){ref-type="table"} shows the comparison of our proposed workflow and the baseline workflow, and details of the numbers of correctly and incorrectly disassembled molecules using the baseline workflow are shown in Table [6](#Tab6){ref-type="table"}. Among the molecules that were not correctly disassembled by the Metabolic Disassembler, five were correctly disassembled by the baseline workflow (Fig. [12](#Fig12){ref-type="fig"}). The baseline workflow does not depend on the distinction of aromatic bonds, which led to these successful cases. However, our proposed workflow generally performed better than the baseline workflow. The baseline workflow used the Tanimoto coefficient of Morgan fingerprint, which takes values from 0.0 (dissimilar) to 1.0 (similar). Importantly, 1.0 does not always mean identical. In addition, when the molecular similarity is low it is more difficult to interpret the obtained fragment. The proposed workflow performs exact matching, which provides easier interpretation. Table 5Comparison of the performance of the proposed Metabolic Disassembler workflow and the baseline workflowsCorrectIncorrectAccuracyProposed workflow903400.958Baseline workflow using the genetic algorithm4904530.520 Table 6Accuracy of the baseline workflow for each metabolic mapMap numberName of the pathway mapCorrectIncorrectNumber of moleculesAccuracy00231Puromycin biosynthesis46100.40000232Caffeine metabolism113140.78600254Aflatoxin biosynthesis138210.61900261Monobactam biosynthesis915240.37500311Penicillin and cephalosporin biosynthesis84120.66700331Clavulanic acid biosynthesis8081.00000332Carbapenem biosynthesis1310230.56500333Prodigiosin biosynthesis110110.09100401Novobiocin biosynthesis135180.72200402Benzoxazinoid biosynthesis6061.00000403Indole diterpene alkaloid biosynthesis1317300.43300404Staurosporine biosynthesis1121320.34400405Phenazine biosynthesis421250.16000521Streptomycin biosynthesis411150.26700524Neomycin, kanamycin and gentamicin biosynthesis3930690.56500525Acarbose and validamycin biosynthesis209290.69000901Indole alkaloid biosynthesis3026560.53600940Phenylpropanoid biosynthesis2530550.45500941Flavonoid biosynthesis4221630.66700942Anthocyanin biosynthesis3231630.50800943Isoflavonoid biosynthesis3227590.54200944Flavone and flavonol biosynthesis3712490.75500945Stilbenoid, diarylheptanoid and gingerol biosynthesis1013230.43500950Isoquinoline alkaloid biosynthesis3168990.31300960Tropane, piperidine and pyridine alkaloid biosynthesis1642580.27600965Betalain biosynthesis713200.35000966Glucosinolate biosynthesis476530.88701058Acridone alkaloid biosynthesis123150.800Total (without redundancy)4904539430.520 Fig. 12The molecules that were correctly disassembled by the baseline workflow but not by the proposed workflow

Discussion {#Sec12}
==========

Our proposed workflow correctly disassembled 903 molecules, but incorrectly disassembled 40 molecules. The causes of the incorrect disassembly are given in Table [7](#Tab7){ref-type="table"}. Table 7Causes of incorrect disassemblyMap numberMCS searchChange in ring structuresUse of PBUsFatty acid and polyketide biosynthesisShortage of BUsOthersTotal00254040000400332000001100333500500100040100000110040530000030052400002020090100100010094030001040094320000020095010000010096050006011Total194159240

The substructure search methods caused most of the incorrect results. The HasSubstructMatch and GetSubstructMatch methods in RDKit were used for the substructure search, and these methods distinguish aromatic bond from conjugated double bonds. Our workflow allowed ambiguous bonds in limited circumstances, making it possible to cope with the metabolic reaction to form an aromatic ring by ring closure. However, three molecules, coumestrol (C10205), phenazine-1,6-dicarboxylic acid (C12119), and papaverine (C06533), were incorrectly disassembled. We decided not to apply this rule if the number of aromatic bonds in the query molecule was ≤16 and because of this, six molecules, anhydroglycinol (C10200), 2-heptyl-4-quinolone (C20643), 2-heptyl-3-hydroxy-4-quinolone (C20643), coumarin (C05851), scopoletin (C01752), and scopolin (C01527), were incorrectly disassembled. Among the nine incorrectly disassembled molecules, coumarin, scopoletin, scopolin, coumestrol, and papaverine were correctly disassembled by the baseline approach, as explained above. However, the other four molecules were incorrectly disassembled by both workflows. We used the FindMCS method in RDKit to allow ambiguous matching, but this method easily leads to an increase in the calculation time and a decrease in interpretability. Additionally, the five molecules in map00960, slaframine (C06185), 13-(2-methylcrotonoyl)oxylupanine (C04170), 13-hydroxylupanine (C02621), pseudopelletierine (C10865), and calystegin A3 (C10850), were incorrectly disassembled despite of the presence of relevant BUs. This was caused by the GetSubstructMatch method in RDKit, which returns only the first found substructure even if theoretically there are more substructures, as shown in the example in Fig. [13](#Fig13){ref-type="fig"}. This problem could be solved by using GetSubstructMatches in RDKit, which returns all possible combinations, instead of GetSubstructMatch. However, this method easily causes an increase in the calculation time and, thus, it is not efficient enough to be applied in a simple way. Therefore, the future improvement of these problems would include the development of a more suitable method for the substructure search. Fig. 13Substructure search of cadaverine against 13-hydroxylupanine.The substructures highlighted in red correspond to the query cadaverine. The substructures in green rare those already matched to other substructures. The GetSubstructMatch method of RDKit returns only the first result found, even though theoretically there are more possible results

Some of the other unsuccessful disassembles were caused by rearrangements of the ring structures. For example, the structures of the fused rings in aflatoxin B1 (C06800), B2 (C16753), G1 (C16755), and G2 (C16754) were different from those of the respective precursors, which caused the incorrect disassembly. This problem could be remedied by adding more substructures to the BUL; however, this is not realistic.

We introduced PBUs with the aim of shortening the calculation time, especially for molecules that contain sugar residues. We also compared the algorithms that did and did not use PBUs, taking lampranthin II (C08552), which has a betalamic acid (C08538) moiety and saccharide residues, as an example (Fig. [14a](#Fig14){ref-type="fig"}). The computational time was measured five times both before and after the introduction of the PBUs. The computational times before and after the introduction of the PBUs were 208.58 ± 2.46 s and 4.38 ± 0.11 s, respectively; therefore, we concluded that introducing the PBUs significantly improved the computational speed. We found a case where introducing the PBUs led to an incorrect disassembly (Fig. [14b, c](#Fig14){ref-type="fig"}); however, this is the only incorrect case that we found, implying this was not a major problem. Fig. 14Effects of preferential biosynthetic units on disassembly by the Metabolic Disassembler. (**a**) Disassembly of lampranthin II. (**b**) Biosynthesis of strictosidine. (**c**) Incorrect disassembly of strictosidine

In this study, we did not focus on terpenoids and polyketides, which were mainly in the metabolism map 1.9 class. The appropriate BUs of terpenoids and polyketides would be acetyl-CoA and so on, however, adding these BUs could not solve the problem. In this and other studies, manual curations are important for good performance. BBUs and DBUs were manually selected in order to appropriately disassemble molecules, and PBUs were selected in order to shorten the unnecessary computational time. Enhancement of the BUL could improve the coverage but may increase the incorrect substructure matches. We already examined our manual curation, and the current BUs are the best at this moment. When it becomes apparent that some other secondary metabolites originate from other pathways, the enhancement of BUs may work well.

In fact, the 1.10 class also contains some terpenoids and polyketides and our proposed workflow produced incorrect disassembles for them. The four molecules in map000333, 2-methyl-3-n-amyl-dihydropyrrole (C21571), 2-methyl-3-n-amyl-pyrrole (C21572), 4-keto-2-undecylpyrroline (C21573), and 2-undecylpyrrole (C21574), are generated by amination and cyclization of fatty acids, but do not originate from L-proline as incorrectly indicated by our proposed workflow. Similarly, for the fatty acid dodecanoic acid (C02679) in map000333, the desired combination is the six C~2~ units that originate from malonyl-CoA (C00083). However, this molecule was excluded from the calculation because the number of fragments exceeded the upper limit.

The BUL could not support cases where the number of atoms decreased in the BU or when a double bond was generated in a BU by cyclization and subsequent oxidation. For example, to cope with the C~7~ units derived from octanoyl-CoA (C01944), it is necessary to prepare 19 BUs in which one of the six C--C bonds becomes a double bond. There are 33 combinations for the C~8~ units. Therefore, preparing for other C~n~ units produces an enormous number of BUs and slows the processing speed. In addition, if many straight-chain alkyl groups are registered in the BUL, molecules that did not originate from acetate-malonic acid pathway are adversely affected. Therefore, we concluded that the BUL and our proposed workflow should not be applied to the biosynthesis of terpenoids and polyketides.

Despite the efforts to enhance the BUL to cover a wide range of natural products, there were still nine molecules that were not covered. Apramycin (C01555) and oxyapramycin (C17997) in map00524 are synthesized via paromamine (C01743; Fig. [15a](#Fig15){ref-type="fig"}). These two molecules look like dimers but not exactly, and their biosynthetic pathways are not yet apparent. They contain substructures other than the paromamine (C01743) residue and their origins are unclear, and could not be dealt with by the proposed workflow. 3-(2-Carboxyethenyl)-cis,cis-muconate (C04366) in map00940 is synthetized by oxidative cleavage of the benzene ring of caffeic acid (C01197; Fig. [15b](#Fig15){ref-type="fig"}). This molecule can be dealt with by preparing a relevant BU, but such cleavage was observed only in this molecule. Therefore, we decided we should not prepare such a BU considering its low general use. Senecionine (C06176) and senecionine N-oxide (C15612) in map00960 are synthesized by condensation of retronecine (C06177) and two L-isoleucine (C00407; Fig. [15c](#Fig15){ref-type="fig"}). A carbon atom from each L-isoleucine unit is eliminated during the biosynthesis, but the reaction mechanism is not clear. Lobelanine (C10157), (−)-lobeline (C07475), and (−)-sedamine (C10171) originate from piperideine (C06181), but their biosynthetic mechanisms are not clear (Fig. [15d](#Fig15){ref-type="fig"}). Cytisine (C10763) is biosynthesized by conjugating cadaverine (Fig. [15e](#Fig15){ref-type="fig"}); however, four carbon atoms are eliminated during the biosynthesis, but its complete biosynthetic mechanism has not been revealed. Therefore, appropriate BUs could not be prepared for these molecules. Fig. 15Biosynthesis of the molecules that were not covered the BUL. (**a**) Apramycin and oxyapramycin. (**b**) 3-(2-carboxyethenyl)-cis,cis-muconate. (**c**) Senecionine. (**d**) Lobelanine and (−)-lobeline and (−)-sedamine. (**e**) Cytisine

Although enhancement of the BUL could be a solution, its expansion may increase the number of incorrect substructure matches as well as the calculation time. A sufficient number of BUs is necessary for successful disassembly, therefore, it is necessary to strengthen the BUL while considering its tradeoff.

Conclusions {#Sec13}
-----------

The Metabolic Disassembler disassembles target chemical structures into relevant biosynthetic units that correspond to their starting materials, which is the first step in predicting the biosynthetic pathways of natural products. The users can use the Python program as well as the BUL so that the users do not have to reproduce this knowledge-based system. The Metabolic Disassembler will also help to identify the chemical bonds generated during the biosynthetic pathway, thereby providing valuable information for predicting the biosynthetic pathway of natural products.

Supplementary information
=========================
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**Additional file 1.** Summary of disassembly calculation for each map. Detailed explanation of disassembly calculation for each pathway map.
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